Abbot Financial Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,580
Closed -$202K 133
2022
Q1
$202K Sell
1,580
-47
-3% -$5.67K 0.1% 130
2021
Q4
$201K Hold
1,627
0.09% 131
2021
Q3
$231K Hold
1,627
0.11% 128
2021
Q2
$254K Hold
1,627
0.11% 123
2021
Q1
$253K Hold
1,627
0.11% 116
2020
Q4
$243K Sell
1,627
-103
-6% -$14.5K 0.14% 112
2020
Q3
$229K Hold
1,730
0.15% 104
2020
Q2
$201K Buy
+1,730
New +$199K 0.14% 110
2020
Q1
Sell
-1,730
Closed -$251K 137
2019
Q4
$251K Hold
1,730
0.16% 111
2019
Q3
$231K Buy
+1,730
New +$223K 0.16% 110
2019
Q2
Sell
-1,730
Closed -$215K 123
2019
Q1
$215K Buy
+1,730
New +$197K 0.17% 100
2018
Q4
Sell
-2,245
Closed -$287K 116
2018
Q3
$287K Sell
2,245
-52
-2% -$6.18K 0.21% 90
2018
Q2
$249K Buy
2,297
+155
+7% +$16.9K 0.2% 93
2018
Q1
$227K Hold
2,142
0.18% 92
2017
Q4
$251K Buy
+2,142
New +$242K 0.2% 88

Other funds holding ZBH

Abbot Financial Management's ZBH Position: Q2 2022 in Review

Abbot Financial Management sold out of Zimmer Biomet (ZBH) in Q2 2022, closing a stake of 1,580 shares — an estimated $202K sold.

Abbot Financial Management first reported a position in ZBH in Q4 2017 and held it in 15 quarters. The position peaked at $287K in Q3 2018. 956 funds tracked by Wall St. Rank hold ZBH as of Q2 2022.

  • Abbot Financial Management reported no remaining Zimmer Biomet position as of Q2 2022 after selling out during the quarter.
  • Abbot Financial Management sold 1,580 Zimmer Biomet shares in Q2 2022, an estimated $202K.
  • Abbot Financial Management first reported a position in Zimmer Biomet in Q4 2017 and held it in 15 quarters.
  • Abbot Financial Management's Zimmer Biomet position peaked at $287K in Q3 2018.
  • 956 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2022.

Based on Abbot Financial Management's 13F filing for Q2 2022, filed 9 Aug 2022.